Furthermore, evidence suggests that IL-9 may exacerbate the inflammatory response in the liver of patients with CE by activating the TGF-β/Smad signaling pathway and enhancing IL-9 production in individuals with active CE [23]. The gene discussed is TGFB1; the disease is cholesteryl ester measurement.